Purpose Pharmacokinetic considerations in patients who have undergone Roux-en-Y gastric bypass (RYGB ... and MRP2 = multidrug-resistance-associated protein 2. April Smith, Pharm.D., is Assistant ...
Some results have been hidden because they may be inaccessible to you